DK41289D0 - Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering - Google Patents

Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering

Info

Publication number
DK41289D0
DK41289D0 DK041289A DK41289A DK41289D0 DK 41289 D0 DK41289 D0 DK 41289D0 DK 041289 A DK041289 A DK 041289A DK 41289 A DK41289 A DK 41289A DK 41289 D0 DK41289 D0 DK 41289D0
Authority
DK
Denmark
Prior art keywords
hiv
specific
synthesis
reneating
immundefect
Prior art date
Application number
DK041289A
Other languages
English (en)
Other versions
DK41289A (da
Inventor
Stephen Oroszlan
Terry Duane Copeland
Original Assignee
Bionetics Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionetics Research Inc filed Critical Bionetics Research Inc
Publication of DK41289D0 publication Critical patent/DK41289D0/da
Publication of DK41289A publication Critical patent/DK41289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK041289A 1987-06-01 1989-01-30 Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering DK41289A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/057,183 US5252477A (en) 1987-06-01 1987-06-01 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
PCT/US1988/001849 WO1988009815A1 (en) 1987-06-01 1988-06-01 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Publications (2)

Publication Number Publication Date
DK41289D0 true DK41289D0 (da) 1989-01-30
DK41289A DK41289A (da) 1989-01-30

Family

ID=22009015

Family Applications (1)

Application Number Title Priority Date Filing Date
DK041289A DK41289A (da) 1987-06-01 1989-01-30 Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering

Country Status (10)

Country Link
US (2) US5252477A (da)
EP (1) EP0316429B1 (da)
JP (1) JPH02500408A (da)
KR (1) KR890701738A (da)
AT (1) ATE105859T1 (da)
AU (1) AU630590B2 (da)
DE (1) DE3889625T2 (da)
DK (1) DK41289A (da)
FI (1) FI890459A7 (da)
WO (1) WO1988009815A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252477A (en) * 1987-06-01 1993-10-12 The United States Of America As Represented By The United States Department Of Health And Human Services Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
US5637488A (en) * 1987-06-01 1997-06-10 The United States Of America As Represented By The Department Of Health And Human Services HIV protease gene and method for its expression
CA1340748C (en) * 1988-07-13 1999-09-14 Stephen Oroszlan Synthetic hiv protease gene and method for its expression
US5866123A (en) * 1990-04-13 1999-02-02 Research Development Foundation Gene encoding cationic amino acid transporter protein
US5147369A (en) * 1991-07-01 1992-09-15 Wagner Michael A Forceps and method for nuclear fragment removal
US5554728A (en) * 1991-07-23 1996-09-10 Nexstar Pharmaceuticals, Inc. Lipid conjugates of therapeutic peptides and protease inhibitors
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US5872210A (en) * 1995-10-05 1999-02-16 The United States Of America As Represented By The Department Of Health And Human Services Transframe peptide inhibitor of viral protease
US6333303B1 (en) 1996-04-30 2001-12-25 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins
US6531125B1 (en) 1999-03-02 2003-03-11 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252477A (en) * 1987-06-01 1993-10-12 The United States Of America As Represented By The United States Department Of Health And Human Services Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation

Also Published As

Publication number Publication date
ATE105859T1 (de) 1994-06-15
EP0316429A4 (en) 1991-05-22
EP0316429A1 (en) 1989-05-24
US5354683A (en) 1994-10-11
US5252477A (en) 1993-10-12
EP0316429B1 (en) 1994-05-18
JPH02500408A (ja) 1990-02-15
DE3889625D1 (de) 1994-06-23
DE3889625T2 (de) 1994-09-29
AU1805188A (en) 1989-01-04
KR890701738A (ko) 1989-12-21
DK41289A (da) 1989-01-30
WO1988009815A1 (en) 1988-12-15
FI890459A0 (fi) 1989-01-31
FI890459L (fi) 1989-01-31
FI890459A7 (fi) 1989-01-31
AU630590B2 (en) 1992-11-05

Similar Documents

Publication Publication Date Title
DK41289A (da) Proteolytisk enzym, der er specifikt for human immundefektvirus og en fremgangsmaade til dets syntese og renaturering
ATE250669T1 (de) Proteolytische enzyme und ihre verwendung in waschmitteln
ATE26914T1 (de) Gebogene heftklammer.
ATE80657T1 (de) Mischungen von alpha-amylase zur verfluessigung von staerke.
AU638133B2 (en) Ribosome inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
DK0749478T3 (da) Gærstammer og modificerede albuminer
DE68924775D1 (de) Verwendungen viraler enzyme.
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
DK0387231T3 (da) Hidtil ukendte inhibitorer for retroviral protease
DK0909312T3 (da) Fremgangsmåde til fremstilling af polypeptider
IT1050910B (it) Enzima proteolitico particolarmente per composizioni biodetergenti..e procedimento per la sua preparazione
DE3788216D1 (de) Gentechnologisch hergestellter pankreatischer sekretorischer Trypsininhibitor und seine Varianten.
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
ATE5314T1 (de) Pharmakologisch aktive peptide und deren zusammensetzungen.
DK316984D0 (da) Fremgangsmaade til oploesning af peptider
UA27132C2 (uk) Двофуhкціоhальhі варіаhти урокіhази зі зміцнеhою фібриhолітичhою властивістю і тромбіh-іhгібуючою дією
IT8321281A0 (it) Un vetro-inverso analogo del decapeptide (5-14)dell'angiotensinogeno equino inibitore specifico della renina con elevata resistenza all'idrolisi enzimatica.
ATE109796T1 (de) Gewebeinhibitor für metalloproteasen (timp-2).
ATE125547T1 (de) Hiv protease-hemmer.
EP0236040A3 (en) Amino acid modified prourokinase and method of preparation
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
HUP0001284A2 (hu) Humán prohormon konvertáz 4
NO894362L (no) Fremgangsmaate for selektiv spaltning av fusjonsproteiner.
IL72986A (en) Production of intact recombinant human immune interferon essentially free of proteolytic fragments thereof and pharmaceutical compositions containing such an interferon
DE3774947D1 (de) Alpha-acylamino-aminoalkyl-phosphonat-inhibitor des angiotensin umwandelnden enzyms.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment